Literature DB >> 29314511

Towards a cure for human immunodeficiency virus.

Matthew C Pitman1, Sharon R Lewin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29314511      PMCID: PMC5971165          DOI: 10.1111/imj.13673

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  28 in total

1.  Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.

Authors:  Vivek Jain; Wendy Hartogensis; Peter Bacchetti; Peter W Hunt; Hiroyu Hatano; Elizabeth Sinclair; Lorrie Epling; Tzong-Hae Lee; Michael P Busch; Joseph M McCune; Christopher D Pilcher; Frederick M Hecht; Steven G Deeks
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

2.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

3.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Authors:  Gero Hütter; Daniel Nowak; Maximilian Mossner; Susanne Ganepola; Arne Müssig; Kristina Allers; Thomas Schneider; Jörg Hofmann; Claudia Kücherer; Olga Blau; Igor W Blau; Wolf K Hofmann; Eckhard Thiel
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

4.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

Review 5.  Immune checkpoint blockade in infectious diseases.

Authors:  Michelle N Wykes; Sharon R Lewin
Journal:  Nat Rev Immunol       Date:  2017-10-09       Impact factor: 53.106

6.  Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques.

Authors:  Luca Micci; Emily S Ryan; Rémi Fromentin; Steven E Bosinger; Justin L Harper; Tianyu He; Sara Paganini; Kirk A Easley; Ann Chahroudi; Clarisse Benne; Sanjeev Gumber; Colleen S McGary; Kenneth A Rogers; Claire Deleage; Carissa Lucero; Siddappa N Byrareddy; Cristian Apetrei; Jacob D Estes; Jeffrey D Lifson; Michael Piatak; Nicolas Chomont; Francois Villinger; Guido Silvestri; Jason M Brenchley; Mirko Paiardini
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

7.  Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.

Authors:  Line Vibholm; Mariane H Schleimann; Jesper F Højen; Thomas Benfield; Rasmus Offersen; Katrine Rasmussen; Rikke Olesen; Anders Dige; Jørgen Agnholt; Judith Grau; Maria Buzon; Burghardt Wittig; Mathias Lichterfeld; Andreas Munk Petersen; Xutao Deng; Mohamed Abdel-Mohsen; Satish K Pillai; Sofie Rutsaert; Wim Trypsteen; Ward De Spiegelaere; Linos Vandekerchove; Lars Østergaard; Thomas A Rasmussen; Paul W Denton; Martin Tolstrup; Ole S Søgaard
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

8.  Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

Authors:  Julian H Elliott; Fiona Wightman; Ajantha Solomon; Khader Ghneim; Jeffrey Ahlers; Mark J Cameron; Miranda Z Smith; Tim Spelman; James McMahon; Pushparaj Velayudham; Gregor Brown; Janine Roney; Jo Watson; Miles H Prince; Jennifer F Hoy; Nicolas Chomont; Rémi Fromentin; Francesco A Procopio; Joumana Zeidan; Sarah Palmer; Lina Odevall; Ricky W Johnstone; Ben P Martin; Elizabeth Sinclair; Steven G Deeks; Daria J Hazuda; Paul U Cameron; Rafick-Pierre Sékaly; Sharon R Lewin
Journal:  PLoS Pathog       Date:  2014-11-13       Impact factor: 6.823

9.  Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys.

Authors:  Erica N Borducchi; Crystal Cabral; Kathryn E Stephenson; Jinyan Liu; Peter Abbink; David Ng'ang'a; Joseph P Nkolola; Amanda L Brinkman; Lauren Peter; Benjamin C Lee; Jessica Jimenez; David Jetton; Jade Mondesir; Shanell Mojta; Abishek Chandrashekar; Katherine Molloy; Galit Alter; Jeffrey M Gerold; Alison L Hill; Mark G Lewis; Maria G Pau; Hanneke Schuitemaker; Joseph Hesselgesser; Romas Geleziunas; Jerome H Kim; Merlin L Robb; Nelson L Michael; Dan H Barouch
Journal:  Nature       Date:  2016-11-09       Impact factor: 49.962

10.  Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.

Authors:  Angela Tsai; Alivelu Irrinki; Jasmine Kaur; Tomas Cihlar; George Kukolj; Derek D Sloan; Jeffrey P Murry
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

View more
  1 in total

Review 1.  The HIV Reservoir in Monocytes and Macrophages.

Authors:  Michelle E Wong; Anthony Jaworowski; Anna C Hearps
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.